Preclinical evaluation of MVA as vaccine against monkeypox virus (MKPXV) experimental infection in cynomolgus macaques
- Funded by Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)
- Total publications:0 publications
Grant number: ANRS0298
Grant search
Key facts
Disease
mpoxStart & end year
2022Known Financial Commitments (USD)
$309,699.91Funder
Agence nationale de recherche sur le sida et les hépatites virale [National Agency for AIDS Research] (ANRS)Principal Investigator
TOURNIER Jean-NicolasResearch Location
FranceLead Research Institution
Institut de Recherche Biomédical des ArméesResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Pre-clinical studiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicableMpox Research Priorities
Vaccines research, development and implementationMpox Research Sub Priorities
Development of equitable, accessible, safe and effective vaccines
Abstract
N/A